Skip to main content
Fig.2 | Gut Pathogens

Fig.2

From: A triad of gut dysbiosis, dysregulated immunity, and ‘leaky’ gut characterize HCMV associated neonatal cholestasis

Fig.2

Estimation of fecal inflammatory markers—(A) Levels of fecal cytokines and (B) gut inflammatory markers assessed by ELISA in HCMV infected infants with NC (N = 15 each) compared to healthy controls (N = 10); (C) Significant ROC curve analysis of fecal inflammatory markers between HCMV infected infants with NC. Data represented as Median. Statistical significance was calculated by and Kruskal–Wallis test with Dunn’s multiple comparison test; *, p < 0.05; **, p < 0.01, ***, p < 0.001; and ****, p < 0.001

Back to article page